Study of Efficacy and Safety of LTP001 in Pulmonary Arterial Hypertension
Clinical trial NCT05135000 · TERMINATED
Trial details
- NCT number
- NCT05135000
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-30
- Primary completion
- 2024-03-20
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.